144 related articles for article (PubMed ID: 16263416)
1. Efficient gene transfer into primary human natural killer cells by retroviral transduction.
Guven H; Konstantinidis KV; Alici E; Aints A; Abedi-Valugerdi M; Christensson B; Ljunggren HG; Dilber MS
Exp Hematol; 2005 Nov; 33(11):1320-8. PubMed ID: 16263416
[TBL] [Abstract][Full Text] [Related]
2. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
[TBL] [Abstract][Full Text] [Related]
3. Retroviral gene transfer into primary human natural killer cells.
Alici E; Sutlu T; Sirac Dilber M
Methods Mol Biol; 2009; 506():127-37. PubMed ID: 19110624
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery.
Crcareva A; Saito T; Kunisato A; Kumano K; Suzuki T; Sakata-Yanagimoto M; Kawazu M; Stojanovic A; Kurokawa M; Ogawa S; Hirai H; Chiba S
Exp Hematol; 2005 Dec; 33(12):1459-69. PubMed ID: 16338488
[TBL] [Abstract][Full Text] [Related]
5. High-efficient lentiviral vector-mediated gene transfer into primary human NK cells.
Micucci F; Zingoni A; Piccoli M; Frati L; Santoni A; Galandrini R
Exp Hematol; 2006 Oct; 34(10):1344-52. PubMed ID: 16982327
[TBL] [Abstract][Full Text] [Related]
6. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
7. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector.
Becknell B; Trotta R; Yu J; Ding W; Mao HC; Hughes T; Marburger T; Caligiuri MA
J Immunol Methods; 2005 Jan; 296(1-2):115-23. PubMed ID: 15680156
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors.
Schroers R; Hildebrandt Y; Hasenkamp J; Glass B; Lieber A; Wulf G; Piesche M
Exp Hematol; 2004 Jun; 32(6):536-46. PubMed ID: 15183894
[TBL] [Abstract][Full Text] [Related]
9. Introduction of shRNAs into primary NK cells with lentivirus.
Kung SK
Methods Mol Biol; 2010; 612():233-47. PubMed ID: 20033645
[TBL] [Abstract][Full Text] [Related]
10. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of alpha-Gal on primary human endothelium does not confer susceptibility to NK cell cytotoxicity or increased NK cell adhesion.
He Z; Ehrnfelt C; Kumagai-Braesch M; Islam KB; Holgersson J
Eur J Immunol; 2004 Apr; 34(4):1185-95. PubMed ID: 15048730
[TBL] [Abstract][Full Text] [Related]
12. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
[TBL] [Abstract][Full Text] [Related]
13. Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector.
Vogt S; Ueblacker P; Geis C; Wagner B; Wexel G; Tischer T; Krüger A; Plank C; Anton M; Martinek V; Imhoff AB; Gansbacher B
Biomaterials; 2008 Mar; 29(9):1242-9. PubMed ID: 18078987
[TBL] [Abstract][Full Text] [Related]
14. Targeting of products of genes to tumor sites using adoptively transferred A-NK and T-LAK cells.
Goding S; Yang Q; Mi Z; Robbins PD; Basse PH
Cancer Gene Ther; 2007 May; 14(5):441-50. PubMed ID: 17273184
[TBL] [Abstract][Full Text] [Related]
15. Forced expression of Id2 in fetal thymic T cell progenitors allows some of their progeny to adopt NK cell fate.
Fujimoto S; Ikawa T; Kina T; Yokota Y
Int Immunol; 2007 Oct; 19(10):1175-82. PubMed ID: 17698981
[TBL] [Abstract][Full Text] [Related]
16. Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer.
Lamana ML; Bueren JA; Vicario JL; Balas A
Gene Ther; 2004 Mar; 11(5):474-82. PubMed ID: 14724690
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.
Tam YK; Martinson JA; Doligosa K; Klingemann HG
Cytotherapy; 2003; 5(3):259-72. PubMed ID: 12850795
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL.
Jiang W; Zhang J; Tian Z
Cytotherapy; 2008; 10(3):265-74. PubMed ID: 18418772
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
[TBL] [Abstract][Full Text] [Related]
20. In vitro development of human Killer-Immunoglobulin Receptor-positive NK cells.
Cichocki F; Miller JS
Methods Mol Biol; 2010; 612():15-26. PubMed ID: 20033631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
